|
acridinium I
|
C403604 |
|
|
2-amino-5-(3,4,5-trimethoxyphenyl)pyrazine
|
C403605 |
|
|
PubMed
|
D039781 |
[A bibliographic database that includes MEDLINE as its primary subset. It is produced by the National Center for Biotechnology Information (NCBI), part of the NATIONAL LIBRARY OF MEDICINE. PubMed, which is searchable through NLM's Web site, also includes access to additional citations to selected life sciences journals not in MEDLINE, and links to other resources such as the full-text of articles at participating publishers' Web sites, NCBI's molecular biology databases, and PubMed Central.
] |
|
myoinositol hexaphosphate adenosine diphosphate phosphotransferase
|
C021820 |
|
|
myo-inositol-1 (or 4)-monophosphatase
|
C021822 |
|
|
myo-inositol-1-phosphate dehydrogenase
|
C021823 |
|
|
Therapy, Soft Tissue
|
D064746 |
[The assessment, treatment, and management of soft tissue injury or dysfunction. Therapy is designed to reduce tension and irritation in affected tissues and may include MASSAGE; muscle stretching, or direct pressure on muscles, connective tissue, and TRIGGER POINTS.
] |
|
myristic acid reductase
|
C021825 |
|
|
Lansoprazole
|
D064747 |
[A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
] |
|
myxobacter alpha-lytic proteinase
|
C021826 |
|
|
Dexlansoprazole
|
D064748 |
[The R-isomer of lansoprazole that is used to treat severe GASTROESOPHAGEAL REFLUX DISEASE.
] |
|
Retrocaval Ureter
|
D064749 |
[A rare congenital abnormality resulting in the URETER passing dorsal to and being obstructed by the INFERIOR VENA CAVA.
] |
|
Revalor
|
C021828 |
|
|
isoborneol glucuronide
|
C021829 |
|
|
Drug Resistance, Fungal
|
D025141 |
[The ability of fungi to resist or to become tolerant to chemotherapeutic agents, antifungal agents, or antibiotics. This resistance may be acquired through gene mutation.
] |
|
Bariatric Surgery
|
D050110 |
[Surgical procedures aimed at affecting metabolism and producing major WEIGHT REDUCTION in patients with MORBID OBESITY.
] |
|
Imino Sugars
|
D050111 |
[Sugars in which the OXYGEN is replaced by a NITROGEN atom. This substitution prevents normal METABOLISM resulting in inhibition of GLYCOSIDASES and GLYCOSYLTRANSFERASES.
] |
|
Imino Pyranoses
|
D050112 |
[Six-carbon pyranose sugars in which the OXYGEN is replaced by a NITROGEN atom.
] |
|
Imino Furanoses
|
D050113 |
[Five-carbon furanose sugars in which the OXYGEN is replaced by a NITROGEN atom.
] |
|
Dexrazoxane
|
D064730 |
[The (+)-enantiomorph of razoxane.
] |
